Downloadable Slideset

Share

Program Content

Activities

  • CAR T-Cell Tx in R/R FL
    CAR T-Cell Therapy in the Management of Relapsed/Refractory Follicular Lymphoma
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2023

  • Bispecific Antibodies in R/R FL
    Bispecific Antibodies in the Management of Relapsed/Refractory Follicular Lymphoma
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2023

  • FL Tx Landscape and EZH2i in R/R FL
    Follicular Lymphoma Treatment Landscape and EZH2 Inhibition in Relapsed/Refractory Disease
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2023

Faculty

cover img faculity

Peter Martin, MD

Chief, Lymphoma Program
Professor of Medicine
Weill Cornell Medicine
Meyer Cancer Center
New York, New York

cover img faculity

Sonali M. Smith, MD, FASCO

Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Co-Leader, Cancer Service Line
The University of Chicago
Chicago, Illinois

cover img faculity

Julie M. Vose, MD, MBA

Newmann M. and Milde E. Harris Professor
Chief, Hematology/Oncology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

Supported by educational grants from Genentech, a member of the Roche Group; Genmab; Ipsen Biopharmaceuticals, Inc; and Regeneron Pharmaceuticals, Inc.

Genentech, a member of the Roche Group

Genmab

Ipsen Biopharmaceuticals Inc

Regeneron Pharmaceuticals, Inc